Transportation Healthcare Sector

TuHURA Biosciences

Market Cap: US$138.9m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Scancell Holdings

Market Cap: UK£102.7m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

Nektar Therapeutics

Market Cap: US$137.6m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Aldeyra Therapeutics

Market Cap: US$136.6m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Baird Medical Investment Holdings

Market Cap: US$136.0m

Engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China.

Liminatus Pharma

Market Cap: US$135.8m

Operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

DocGo

Market Cap: US$134.8m

Provides mobile health and medical transportation services in the United States and the United Kingdom.

Global Cord Blood

Market Cap: US$133.9m

Provides umbilical cord blood storage and ancillary services in the People's Republic of China.

Greenwich LifeSciences

Market Cap: US$132.6m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.

TerrAscend

Market Cap: CA$181.8m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

KORU Medical Systems

Market Cap: US$132.0m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

Enanta Pharmaceuticals

Market Cap: US$131.7m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Pro-Dex

Market Cap: US$131.6m

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.

Prenetics Global

Market Cap: US$130.3m

A consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally.

Oneview Healthcare

Market Cap: AU$201.6m

Develops and sells software services for the healthcare sector in Ireland, the United States, Australia, Ireland, the Middle East, and Asia.

Pulmonx

Market Cap: US$128.8m

A commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.

Ventyx Biosciences

Market Cap: US$128.8m

A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.

Nkarta

Market Cap: US$128.4m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Black Diamond Therapeutics

Market Cap: US$127.9m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

EUDA Health Holdings

Market Cap: US$127.6m

Operates as a healthcare specialty company.

Protalix BioTherapeutics

Market Cap: US$126.6m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

AOTI

Market Cap: UK£93.1m

Produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers worldwide.

RAPT Therapeutics

Market Cap: US$123.1m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.

BioSig Technologies

Market Cap: US$122.5m

A medical technology company, provides digital signal processing technology platform services in the United States.

Protara Therapeutics

Market Cap: US$120.8m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Theratechnologies

Market Cap: CA$164.6m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Elicio Therapeutics

Market Cap: US$119.9m

A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.

Spero Therapeutics

Market Cap: US$119.1m

A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.

Jin Medical International

Market Cap: US$119.0m

Engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury.

Lyell Immunopharma

Market Cap: US$118.9m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

InfuSystem Holdings

Market Cap: US$117.5m

Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

eXoZymes

Market Cap: US$116.3m

A development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application.

Neumora Therapeutics

Market Cap: US$116.2m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

Achieve Life Sciences

Market Cap: US$115.8m

A clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction.

Cibus

Market Cap: US$114.5m

An agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products.

HLS Therapeutics

Market Cap: CA$156.6m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.